Current Opinion in Allergy and Clinical Immunology

Papers
(The median citation count of Current Opinion in Allergy and Clinical Immunology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Association between silicosis and autoimmune disease50
Biologicals in IgE-mediated food allergy32
The development of the DEFASE project30
Updates in school-based asthma management29
Food-labeling issues for severe food-allergic consumers25
Occupational causes of chronic obstructive pulmonary disease: an update23
MicroCrystalline Tyrosine-adsorbed immunotherapy21
New molecules for atopic dermatitis treatment beyond biological therapy21
Health disparities in allergic diseases18
Antibody therapy for COVID-1917
Endotypes of occupational asthma17
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules15
Psychosocial impact of ocular surface allergic inflammatory disorders15
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review15
Editorial: Advances in drug hypersensitivity reactions14
The use of environmental exposure chambers in studies related to ocular surface effects13
SARS-CoV-2 vaccination in primary antibody deficiencies: an overview on efficacy, immunogenicity, durability of immune response and safety13
Clinical outcomes of AIT in the elderly population12
Management and treatment of perioperative hypersensitivity12
Evaluating the glucagon-like peptide-1 receptor in managing asthma12
The pathogenetic role of Th17 immune response in atopic dermatitis12
Optimal use of intranasal corticosteroids and intranasal saline, is there a clear answer?11
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis11
Coronavirus disease 2019 and severe asthma11
Gene therapy for inborn error of immunity – current status and future perspectives11
Advances in gene therapy for inborn errors of immunity10
What molecular allergy teaches us about genetics and epidemiology of allergies10
Role of biologics in severe food allergy10
Clinical remission in severe asthma: lights and shadows on an ambitious goal9
Anaphylaxis: glimpse into the future, attention to the present9
The risk of anaphylaxis on holidays9
Chronic urticaria: not only after COVID-19 vaccination9
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency9
Beyond the appearances: exploring complexities in anaphylaxis differential diagnosis9
Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker9
The role of type 2 diabetes in the severity of adult asthma8
Atopic dermatitis endotypes: knowledge for personalized medicine8
Exploring the management of recurrent angioedema caused by different mechanisms8
Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies8
New evidence in food allergies treatment8
Understanding the heterogeneity of childhood allergic sensitization and its relationship with asthma8
Moderate asthma: burden, mechanisms and therapeutic perspectives8
Basophil activation test in food allergy: is it ready for real-time?8
Classifying cephalosporins: from generation to cross-reactivity8
Personalized management for unmet needs with food allergy8
Social determinants of health and asthma8
Food allergy: new therapeutic options open deeper questions7
Role of the ocular surface microbiome in allergic eye diseases7
Highlights of the treatment of allergic rhinitis according to Chinese guidelines7
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches7
Biomarkers in the diagnosis of mast cell activation7
Regulatory T-cells in asthma6
The impact of obesity on immune function in pediatric asthma6
The complexity in DNA methylation analysis of allergic diseases6
Inborn errors of immunity underlying defective T-cell memory6
Editorial introductions6
Updates on treatment options in aspirin exacerbated respiratory disease6
Editorial introductions6
Editorial: Pharmacotherapy and evidence based medicine6
Dietary strategies for the prevention of asthma in children6
An update on patient reported outcomes in type 2 inflammation airway disease6
Consequences of severe asthma exacerbations6
Neurostimulation for dry eye disease5
Long-term outcome of occupational asthma with different etiology5
Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma5
E-cigarettes and asthma in adolescents5
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis5
Economic burden of drug-induced anaphylaxis: what can we do better?5
Anaphylaxis due to antiallergic and antiasthmatic biologics5
Editorial introductions5
Anaphylaxis: unraveling the mysteries and new perspectives5
Endotypic heterogeneity and pathogenesis in chronic rhinosinusitis5
Is immunotherapy safe for treatment of severe asthma5
Regular consumption following early introduction of allergenic foods and aggressive treatment of eczema are necessary for preventing the development of food allergy in children5
Perspectives in the validation of DEFASE: a paradigm shift in food allergy management5
Update on the use of allergen challenge chambers in immunotherapy: clinical implications5
Editorial introductions5
Air pollution and childhood asthma5
Wood dust and asthma5
Where AIRE we now? Where AIRE we going?4
Cow's milk allergy4
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-114
Evidence-based management of eczema: five things that should be done more and five things that should be dropped4
Grading the severity of anaphylaxis4
Clinical phenotypes of adult atopic dermatitis and related therapies4
Occupational inhalant allergy in food handling occupations4
Current strategies for phenotyping and managing asthma in preschool children4
Hymenoptera venom allergy in children and adolescents4
Clinical outcomes of efficacy in food allergen immunotherapy trials4
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management4
Editorial introductions4
Ocular surface disorders: office procedures for the allergist/clinical immunologist4
Ocular surface itch and pain: key differences and similarities between the two sensations4
Exposure to nanoparticles and occupational allergy4
Global burden of pediatric asthma and rhinitis – what we have recently learned from epidemiology4
Liver disease in primary antibody deficiencies4
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist4
Chronic spontaneous urticaria: new evidences on the role of autoimmunity4
How E-cigarettes and vaping can affect asthma in children and adolescents4
Pulmonary function testing for the diagnosis of asthma in preschool children4
Perspectives in precautionary allergen labelling of prepackaged foods after the FAO/WHO consultation4
To mix or not to mix in allergy immunotherapy vaccines4
Neuropathic pain and itch: mechanisms in allergic conjunctivitis4
Molecular diagnosis contribution for personalized medicine3
Editorial introductions3
Nasal nitric oxide flux from the paranasal sinuses3
Fungal bioaerosols as an occupational hazard3
What's new in pediatric asthma and rhinitis phenotypes and endotypes?3
Update on occupational allergy, including asthma, to soluble platinum salts3
Editorial: pharmacotherapy and evidence-based medicine3
Novel occupational causes of hypersensitivity pneumonitis3
Atopic manifestations of inborn errors of immunity3
Atopic endotypes as a modulating factor for SARS-CoV-2 infection: mechanisms and implications3
Environmental exposures: evolving evidence for their roles in adult allergic disorders3
Editorial introductions3
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms3
Strengthening the case for intralymphatic immunotherapy3
Editorial introductions3
Impact of the exposome on food allergy development3
Editorial introductions3
Mast cell conditions and drug allergy: when to suspect and how to manage3
Innate and adaptive immunity in allergic airway disease3
Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data3
Upper and lower airway interactions in children3
Editorial introductions3
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?3
Management of adverse reactions induced by chemotherapy drugs2
Recent advances in the treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome2
Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?2
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma2
Tryptase in drug-induced anaphylaxis: the need for acute and baseline values2
Serum tryptase and drug hypersensitivity: why, how and what? A systematic review2
Editorial: Food allergy: from defense to attack2
Safety of allergen immunotherapy in children2
Exanthematous reactions to drugs in children2
Drug allergy management in the elderly2
Exhaled nitric oxide in asthma: from diagnosis to management2
Ocular involvement in allergic drug reactions2
Diagnosis, management and therapeutic options for eosinophilic esophagitis2
Editorial: pharmacotherapy and evidence-based medicine section2
Editorial introductions2
Real-world evidence of allergen immunotherapy2
Clinically meaningful changes in efficacy outcomes in chronic rhinosinusitis with nasal polyposis2
Anaphylaxis across Europe: are pollen food syndrome and lipid transfer protein allergy so far apart?2
Impact of inflammasomes on the ocular surface2
New insights into the mechanisms of aspirin-exacerbated respiratory disease2
The new indications for biologicals in type 2 diseases: perspectives2
COVID-19 in complex common variable immunodeficiency patients affected by lung diseases2
Transition of care in inborn errors of immunity2
Editorial: What epidemiology can teach us about asthma and allergies pathogenesis?2
Thymic stromal lymphopoietin and alarmins as possible therapeutical targets for asthma2
Exposome mapping in chronic respiratory diseases: the added value of digital technology2
Precision medicine for cow's milk immunotherapy in clinical practice2
Coronavirus disease 2019 and pediatric asthma: friend or foe?2
Precision allergy molecular diagnosis applications in food allergy2
New approaches in childhood asthma treatment2
Food-triggered anaphylaxis in adults2
Tailoring the treatment of type-2 related chronic rhinosinusitis with or without nasal polyps: a comparative analysis of medical and surgical approaches2
Role of pharmacogenomics in T-cell hypersensitivity drug reactions2
Update on aspirin exacerbated respiratory disease with chronic rhinosinusitis2
Hereditary angioedema: current therapeutic management and future approaches2
The effects of the COVID-19 pandemic on the treatment of allergic eye diseases2
0.065593957901001